MML Investors Services
KNSA icon

MML Investors Services’s Kiniksa Pharmaceuticals KNSA Stock Holding History

MML Investors Services’s Portfolio KNSA Stock Details KNSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$340K Buy
5,323
+700
+15% +$36.3K ﹤0.01% 2742
2026
Q1 		$223K Sell
4,623
-637
-12% -$28.2K ﹤0.01% 2762
2025
Q4 		$217K Buy
5,260
+44
+0.8% +$1.76K ﹤0.01% 2837
2025
Q3 		$203K Buy
+5,216
New +$169K ﹤0.01% 2755

Other funds holding KNSA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

MML Investors Services's KNSA Position: Q2 2026 in Review

MML Investors Services increased its Kiniksa Pharmaceuticals (KNSA) stake by 15% in Q2 2026, buying an estimated $36.3K and bringing the position to 5,323 shares worth $340K. The position accounts for ﹤0.01% of the portfolio, ranked #2742.

MML Investors Services first reported a position in KNSA in Q3 2025 and has held it in 4 quarters since. 123 funds tracked by Wall St. Rank hold KNSA as of Q2 2026.

  • MML Investors Services held 5,323 shares of Kiniksa Pharmaceuticals worth $340K as of Q2 2026.
  • MML Investors Services bought 700 Kiniksa Pharmaceuticals shares in Q2 2026, an estimated $36.3K.
  • Kiniksa Pharmaceuticals made up ﹤0.01% of MML Investors Services's portfolio in Q2 2026, its #2742 holding.
  • MML Investors Services first reported a position in Kiniksa Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • 123 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q2 2026.

Based on MML Investors Services's 13F filing for Q2 2026, filed 7 Aug 2026.